img

Global BCG Tuberculosis Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global BCG Tuberculosis Vaccine Market Research Report 2024

According to Mr Accuracy reports’s new survey, global BCG Tuberculosis Vaccine market is projected to reach US$ 36 million in 2034, increasing from US$ 30 million in 2022, with the CAGR of 2.9% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole BCG Tuberculosis Vaccine market research.
Key manufacturers engaged in the BCG Tuberculosis Vaccine industry include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of BCG Tuberculosis Vaccine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole BCG Tuberculosis Vaccine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global BCG Tuberculosis Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
BCG Immunization
BCG Treatment

Segment by Application


Hospital
Clinic
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The BCG Tuberculosis Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 BCG Tuberculosis Vaccine Market Overview
1.1 Product Overview and Scope of BCG Tuberculosis Vaccine
1.2 BCG Tuberculosis Vaccine Segment by Type
1.2.1 Global BCG Tuberculosis Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 BCG Immunization
1.2.3 BCG Treatment
1.3 BCG Tuberculosis Vaccine Segment by Application
1.3.1 Global BCG Tuberculosis Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global BCG Tuberculosis Vaccine Market Size Estimates and Forecasts
1.4.1 Global BCG Tuberculosis Vaccine Revenue 2018-2034
1.4.2 Global BCG Tuberculosis Vaccine Sales 2018-2034
1.4.3 Global BCG Tuberculosis Vaccine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 BCG Tuberculosis Vaccine Market Competition by Manufacturers
2.1 Global BCG Tuberculosis Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global BCG Tuberculosis Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global BCG Tuberculosis Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global BCG Tuberculosis Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of BCG Tuberculosis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Tuberculosis Vaccine, Product Type & Application
2.7 BCG Tuberculosis Vaccine Market Competitive Situation and Trends
2.7.1 BCG Tuberculosis Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest BCG Tuberculosis Vaccine Players Market Share by Revenue
2.7.3 Global BCG Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BCG Tuberculosis Vaccine Retrospective Market Scenario by Region
3.1 Global BCG Tuberculosis Vaccine Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global BCG Tuberculosis Vaccine Global BCG Tuberculosis Vaccine Sales by Region: 2018-2034
3.2.1 Global BCG Tuberculosis Vaccine Sales by Region: 2018-2024
3.2.2 Global BCG Tuberculosis Vaccine Sales by Region: 2024-2034
3.3 Global BCG Tuberculosis Vaccine Global BCG Tuberculosis Vaccine Revenue by Region: 2018-2034
3.3.1 Global BCG Tuberculosis Vaccine Revenue by Region: 2018-2024
3.3.2 Global BCG Tuberculosis Vaccine Revenue by Region: 2024-2034
3.4 North America BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.4.1 North America BCG Tuberculosis Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America BCG Tuberculosis Vaccine Sales by Country (2018-2034)
3.4.3 North America BCG Tuberculosis Vaccine Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.5.1 Europe BCG Tuberculosis Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe BCG Tuberculosis Vaccine Sales by Country (2018-2034)
3.5.3 Europe BCG Tuberculosis Vaccine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific BCG Tuberculosis Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific BCG Tuberculosis Vaccine Sales by Country (2018-2034)
3.6.3 Asia Pacific BCG Tuberculosis Vaccine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.7.1 Latin America BCG Tuberculosis Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America BCG Tuberculosis Vaccine Sales by Country (2018-2034)
3.7.3 Latin America BCG Tuberculosis Vaccine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Tuberculosis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Tuberculosis Vaccine Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa BCG Tuberculosis Vaccine Sales by Country (2018-2034)
3.8.3 Middle East and Africa BCG Tuberculosis Vaccine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BCG Tuberculosis Vaccine Sales by Type (2018-2034)
4.1.1 Global BCG Tuberculosis Vaccine Sales by Type (2018-2024)
4.1.2 Global BCG Tuberculosis Vaccine Sales by Type (2024-2034)
4.1.3 Global BCG Tuberculosis Vaccine Sales Market Share by Type (2018-2034)
4.2 Global BCG Tuberculosis Vaccine Revenue by Type (2018-2034)
4.2.1 Global BCG Tuberculosis Vaccine Revenue by Type (2018-2024)
4.2.2 Global BCG Tuberculosis Vaccine Revenue by Type (2024-2034)
4.2.3 Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global BCG Tuberculosis Vaccine Price by Type (2018-2034)
5 Segment by Application
5.1 Global BCG Tuberculosis Vaccine Sales by Application (2018-2034)
5.1.1 Global BCG Tuberculosis Vaccine Sales by Application (2018-2024)
5.1.2 Global BCG Tuberculosis Vaccine Sales by Application (2024-2034)
5.1.3 Global BCG Tuberculosis Vaccine Sales Market Share by Application (2018-2034)
5.2 Global BCG Tuberculosis Vaccine Revenue by Application (2018-2034)
5.2.1 Global BCG Tuberculosis Vaccine Revenue by Application (2018-2024)
5.2.2 Global BCG Tuberculosis Vaccine Revenue by Application (2024-2034)
5.2.3 Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global BCG Tuberculosis Vaccine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck BCG Tuberculosis Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Sanofi Pasteur BCG Tuberculosis Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Japan BCG Lab BCG Tuberculosis Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 China National Biotec BCG Tuberculosis Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Serum Institute of India BCG Tuberculosis Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Intervax BCG Tuberculosis Vaccine Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL BCG Tuberculosis Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GSBPL BCG Tuberculosis Vaccine Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Tuberculosis Vaccine Industry Chain Analysis
7.2 BCG Tuberculosis Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Tuberculosis Vaccine Production Mode & Process
7.4 BCG Tuberculosis Vaccine Sales and Marketing
7.4.1 BCG Tuberculosis Vaccine Sales Channels
7.4.2 BCG Tuberculosis Vaccine Distributors
7.5 BCG Tuberculosis Vaccine Customers
8 BCG Tuberculosis Vaccine Market Dynamics
8.1 BCG Tuberculosis Vaccine Industry Trends
8.2 BCG Tuberculosis Vaccine Market Drivers
8.3 BCG Tuberculosis Vaccine Market Challenges
8.4 BCG Tuberculosis Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global BCG Tuberculosis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global BCG Tuberculosis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global BCG Tuberculosis Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global BCG Tuberculosis Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global BCG Tuberculosis Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global BCG Tuberculosis Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market BCG Tuberculosis Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of BCG Tuberculosis Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of BCG Tuberculosis Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of BCG Tuberculosis Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of BCG Tuberculosis Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global BCG Tuberculosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Tuberculosis Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global BCG Tuberculosis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global BCG Tuberculosis Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global BCG Tuberculosis Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global BCG Tuberculosis Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global BCG Tuberculosis Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global BCG Tuberculosis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global BCG Tuberculosis Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global BCG Tuberculosis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global BCG Tuberculosis Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America BCG Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America BCG Tuberculosis Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America BCG Tuberculosis Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America BCG Tuberculosis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America BCG Tuberculosis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe BCG Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe BCG Tuberculosis Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe BCG Tuberculosis Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe BCG Tuberculosis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe BCG Tuberculosis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific BCG Tuberculosis Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific BCG Tuberculosis Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific BCG Tuberculosis Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific BCG Tuberculosis Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific BCG Tuberculosis Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America BCG Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America BCG Tuberculosis Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America BCG Tuberculosis Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America BCG Tuberculosis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America BCG Tuberculosis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa BCG Tuberculosis Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa BCG Tuberculosis Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa BCG Tuberculosis Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa BCG Tuberculosis Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa BCG Tuberculosis Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global BCG Tuberculosis Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global BCG Tuberculosis Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global BCG Tuberculosis Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global BCG Tuberculosis Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global BCG Tuberculosis Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global BCG Tuberculosis Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global BCG Tuberculosis Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global BCG Tuberculosis Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global BCG Tuberculosis Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global BCG Tuberculosis Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global BCG Tuberculosis Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Merck BCG Tuberculosis Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Sanofi Pasteur BCG Tuberculosis Vaccine Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Japan BCG Lab BCG Tuberculosis Vaccine Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. China National Biotec Corporation Information
Table 86. China National Biotec Description and Business Overview
Table 87. China National Biotec BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. China National Biotec BCG Tuberculosis Vaccine Product
Table 89. China National Biotec Recent Developments/Updates
Table 90. Serum Institute of India Corporation Information
Table 91. Serum Institute of India Description and Business Overview
Table 92. Serum Institute of India BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Serum Institute of India BCG Tuberculosis Vaccine Product
Table 94. Serum Institute of India Recent Developments/Updates
Table 95. Intervax Corporation Information
Table 96. Intervax Description and Business Overview
Table 97. Intervax BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Intervax BCG Tuberculosis Vaccine Product
Table 99. Intervax Recent Developments/Updates
Table 100. GSBPL Corporation Information
Table 101. GSBPL Description and Business Overview
Table 102. GSBPL BCG Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. GSBPL BCG Tuberculosis Vaccine Product
Table 104. GSBPL Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. BCG Tuberculosis Vaccine Distributors List
Table 108. BCG Tuberculosis Vaccine Customers List
Table 109. BCG Tuberculosis Vaccine Market Trends
Table 110. BCG Tuberculosis Vaccine Market Drivers
Table 111. BCG Tuberculosis Vaccine Market Challenges
Table 112. BCG Tuberculosis Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of BCG Tuberculosis Vaccine
Figure 2. Global BCG Tuberculosis Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global BCG Tuberculosis Vaccine Market Share by Type in 2022 & 2034
Figure 4. BCG Immunization Product Picture
Figure 5. BCG Treatment Product Picture
Figure 6. Global BCG Tuberculosis Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global BCG Tuberculosis Vaccine Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global BCG Tuberculosis Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global BCG Tuberculosis Vaccine Market Size (2018-2034) & (US$ Million)
Figure 13. Global BCG Tuberculosis Vaccine Sales (2018-2034) & (K Units)
Figure 14. Global BCG Tuberculosis Vaccine Average Price (US$/Unit) & (2018-2034)
Figure 15. BCG Tuberculosis Vaccine Report Years Considered
Figure 16. BCG Tuberculosis Vaccine Sales Share by Manufacturers in 2022
Figure 17. Global BCG Tuberculosis Vaccine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest BCG Tuberculosis Vaccine Players: Market Share by Revenue in 2022
Figure 19. BCG Tuberculosis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global BCG Tuberculosis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America BCG Tuberculosis Vaccine Sales Market Share by Country (2018-2034)
Figure 22. North America BCG Tuberculosis Vaccine Revenue Market Share by Country (2018-2034)
Figure 23. United States BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe BCG Tuberculosis Vaccine Sales Market Share by Country (2018-2034)
Figure 26. Europe BCG Tuberculosis Vaccine Revenue Market Share by Country (2018-2034)
Figure 27. Germany BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific BCG Tuberculosis Vaccine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific BCG Tuberculosis Vaccine Revenue Market Share by Region (2018-2034)
Figure 34. China BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America BCG Tuberculosis Vaccine Sales Market Share by Country (2018-2034)
Figure 44. Latin America BCG Tuberculosis Vaccine Revenue Market Share by Country (2018-2034)
Figure 45. Mexico BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa BCG Tuberculosis Vaccine Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa BCG Tuberculosis Vaccine Revenue Market Share by Country (2018-2034)
Figure 50. Turkey BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE BCG Tuberculosis Vaccine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of BCG Tuberculosis Vaccine by Type (2018-2034)
Figure 54. Global Revenue Market Share of BCG Tuberculosis Vaccine by Type (2018-2034)
Figure 55. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of BCG Tuberculosis Vaccine by Application (2018-2034)
Figure 57. Global Revenue Market Share of BCG Tuberculosis Vaccine by Application (2018-2034)
Figure 58. Global BCG Tuberculosis Vaccine Price (US$/Unit) by Application (2018-2034)
Figure 59. BCG Tuberculosis Vaccine Value Chain
Figure 60. BCG Tuberculosis Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed